S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)

Lexeo Therapeutics (LXEO) News Today

$13.42
-1.13 (-7.77%)
(As of 12/29/2023 ET)
SourceHeadline
MarketBeat logoLexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - December 25 at 4:18 AM
seekingalpha.com logoLexeo gets orphan drug, fast track status for cardiac gene therapy
seekingalpha.com - December 19 at 7:16 PM
markets.businessinsider.com logoLexeo Therapeutics Says FDA Grants Fast Track And Orphan Drug Designation To LX2020
markets.businessinsider.com - December 18 at 7:42 AM
finance.yahoo.com logoLexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
finance.yahoo.com - December 18 at 7:42 AM
marketbeat.com logoLeerink Partnrs Weighs in on Lexeo Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:LXEO)
marketbeat.com - December 14 at 6:48 AM
markets.businessinsider.com logoStable Execution and Positive Clinical Progress Support $19 Price Target for Lexeo Therapeutics
markets.businessinsider.com - December 14 at 1:07 AM
finance.yahoo.com logoLexeo Therapeutics Inc (LXEO) Reports Q3 2023 Financial Results and Advances Clinical Programs
finance.yahoo.com - December 13 at 9:56 AM
finance.yahoo.com logoLexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - December 11 at 11:59 AM
morningstar.com logoLexeo Therapeutics Inc LXEO
morningstar.com - December 8 at 3:54 PM
marketbeat.com logo
marketbeat.com - November 8 at 9:33 AM
Get Lexeo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter.



LXEO Media Mentions By Week

LXEO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LXEO
News Sentiment

1.61

0.84

Average
Medical
News Sentiment

LXEO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LXEO Articles
This Week

2

1

LXEO Articles
Average Week

Get Lexeo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LXEO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LXEO) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -